Skip to content
The group

Clinicians and scientists, one bench

The clinicians and scientists driving the group's translational pancreatic-cancer research.

David Victor
Principal Investigator

David Victor, MD, PhD

  • Associate Professor, Department of Oncology
  • Medical Oncologist, Regional Cancer Centre

David Victor is a medical oncologist and clinician-scientist working to make pancreatic-cancer treatment more personal — linking each patient's tumour to laboratory models and blood-based markers that help guide therapy. He leads the group's translational programs and its biomarker- and ctDNA-guided clinical trials.

mailEmail

Current Members

Priya Nair
Clinical Research Fellow

Priya Nair, MD

Medical oncology fellow studying predictors of treatment response in pancreatic ductal adenocarcinoma, with a focus on translating molecular profiling into clinical decision-making at the bedside.

mailEmail
Liam O'Brien
Postdoctoral Fellow

Liam O'Brien, PhD

Cancer biologist developing patient-derived organoid models of pancreatic cancer and using them to test how tumours respond to chemotherapy and targeted agents before those choices reach the clinic.

mailEmail
Maria Gonzalez
PhD Student

Maria Gonzalez, MSc

Works on circulating tumour DNA and other blood-based markers for early detection and monitoring of pancreatic cancer, combining assay development with analysis of longitudinal patient cohorts.

mailEmail
Emma Schmidt
Clinical Research Coordinator

Emma Schmidt, MSc

Coordinates patient enrolment, consent, and sample collection across the group's translational studies, and serves as the link between the clinical teams and the research laboratory.

mailEmail